Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PROCYTOX /VIAL Cause Diffuse large b-cell lymphoma recurrent? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with PROCYTOX /VIAL. This represents 37.5% of all adverse event reports for PROCYTOX /VIAL.

6
Reports of Diffuse large b-cell lymphoma recurrent with PROCYTOX /VIAL
37.5%
of all PROCYTOX /VIAL reports
0
Deaths
0
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma recurrent From PROCYTOX /VIAL?

Of the 6 reports.

Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PROCYTOX /VIAL. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does PROCYTOX /VIAL Cause?

Malignant neoplasm progression (6)

What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?

RITUXIMAB (1,359) CYCLOPHOSPHAMIDE (1,007) VINCRISTINE (957) DOXORUBICIN (953) PREDNISONE (738) CYTARABINE (406) DEXAMETHASONE (402) ETOPOSIDE (375) CISPLATIN (306) GEMCITABINE (280)

Related Pages

PROCYTOX /VIAL Full Profile All Diffuse large b-cell lymphoma recurrent Reports All Drugs Causing Diffuse large b-cell lymphoma recurrent PROCYTOX /VIAL Demographics